Explore the full record of transactions filed by Domzalski David, 董事长兼首席执行官. Director active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 33 reports have been published. Activity tracked since 28 May 2021. The latest transaction was disclosed on 23 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Domzalski David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Domzalski David is Président-Directeur Général. He has 32 filings in total, all in the recent sample covered here, linked to VYNE Therapeutics Inc. (XNAS). The most recent transactions run from 2021-06-02 to 2026-04-02, and the most frequent transaction nature is Tax withholding.